Anthony Letai: NIH Distinguished Clinical Investigators Recognized at National Cancer Institute
Anthony Letai/X

Anthony Letai: NIH Distinguished Clinical Investigators Recognized at National Cancer Institute

Anthony Letai, Director of the National Cancer Institute, shared a post on X:

“From pioneering molecular imaging to defining the genetic basis of kidney cancer, Drs. Peter Choyke and Marston Linehan have changed how we diagnose and treat cancer over decades at National Cancer Institute.

Congratulations on this recognition and thank you.”

Drs. Choyke and Linehan Recognized as NIH Distinguished Clinical Investigators

Anthony Letai

Other articles featuring Anthony Letai on OncoDaily.